CYTK vs VTI
Cytokinetics Inc (CYTK) versus Vanguard Total Stock Market Index Fund ETF Shares (VTI) — a side-by-side from cached financials, not a winner call.
Cytokinetics Inc (CYTK) is a biotechnology company listed on US.
Vanguard Total Stock Market Index Fund ETF Shares (VTI) common stock listed on US.
Latest reported CYTK revenue for 2026-06-30 was $28.6M. Net income was -$198.8M. Revenue was up 47.9% from 2026-03-31 to 2026-06-30. CYTK currently screens at market cap $4.05B.
VTI does not have a complete income-statement cache yet.
CYTK currently screens at market cap $4.05B. VTI currently screens at market cap $0.
Not investment advice. Open the CYTK and VTI stock pages for the full models.
Not investment advice.